Comparative Pharmacology
Head-to-head clinical analysis: HIPREX versus MACRODANTIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HIPREX versus MACRODANTIN.
HIPREX vs MACRODANTIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hippuric acid, the active metabolite of methenamine, acidifies urine and releases formaldehyde, which denatures bacterial proteins and nucleic acids, bactericidal activity requires acidic urine (pH < 5.5).
Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that inhibit bacterial acetyl-CoA carboxylase, interfere with bacterial cell wall synthesis, and damage bacterial DNA. It is bactericidal against a broad spectrum of gram-positive and gram-negative bacteria.
1 gram orally twice daily (every 12 hours) with meals
100 mg orally twice daily for 5 days; for uncomplicated UTI. Route: oral. Frequency: twice daily.
None Documented
None Documented
3-6 hours (methenamine); clinical context: prolonged in renal impairment, requiring dose adjustment.
20-60 minutes (prolonged in renal impairment, up to 8 hours in anuria)
Renal excretion: >90% as unchanged drug (methenamine) and formaldehyde; biliary/fecal: <5%.
Renal: 30-40% unchanged, Hepatic metabolism: 60-70% to inactive metabolites, Fecal: <1%
Category C
Category C
Urinary Anti-infective
Urinary Anti-infective